Patrick Haley
Corporate Officer/Principal bij EXELIXIS, INC.
Vermogen: 10 M $ op 31-03-2024
Profiel
Patrick J.
Haley's current job is as the Executive Vice President-Commercial at Exelixis, Inc. His former job was as the Group Manager-Product at Genentech, Inc. from 2007 to 2010.
Mr. Haley completed his undergraduate degree at Duke University and holds an MBA from the Stephen M.
Ross School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EXELIXIS, INC.
0.14% | 23-02-2024 | 419 053 ( 0.14% ) | 10 M $ | 31-03-2024 |
Actieve functies van Patrick Haley
| Bedrijven | Functie | Begin |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 01-11-2014 |
Eerdere bekende functies van Patrick Haley
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2010 |
Opleiding van Patrick Haley
| Duke University | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
